SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-22-000036
Filing Date
2022-06-24
Accepted
2022-06-24 16:05:43
Documents
13
Period of Report
2022-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K anab-20220623.htm   iXBRL 8-K 42472
  Complete submission text file 0001370053-22-000036.txt   221818

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20220623.xsd EX-101.SCH 2181
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20220623_def.xml EX-101.DEF 9045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20220623_lab.xml EX-101.LAB 33262
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20220623_pre.xml EX-101.PRE 20806
7 EXTRACTED XBRL INSTANCE DOCUMENT anab-20220623_htm.xml XML 11001
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 221040057
SIC: 2834 Pharmaceutical Preparations